Literature DB >> 25435266

Active surveillance for low-risk prostate cancer: developments to date.

Chris H Bangma1, Riccardo Valdagni2, Peter R Carroll3, Hein van Poppel4, Laurence Klotz5, Jonas Hugosson6.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25435266     DOI： 10.1016/j.eururo.2014.11.004

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  9 in total

1.  How do prostate cancer patients navigate the active surveillance journey? A 3-year longitudinal study.

Authors:  Paola Dordoni; Fabio Badenchini; Maria Francesca Alvisi; Julia Menichetti; Letizia De Luca; Teresa Di Florio; Tiziana Magnani; Cristina Marenghi; Tiziana Rancati; Riccardo Valdagni; Lara Bellardita
Journal:  Support Care Cancer       Date:  2020-05-18       Impact factor: 3.603

2.  Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.

Authors:  Tiago M de Carvalho; Eveline A M Heijnsdijk; Harry J de Koning
Journal:  Cancer       Date:  2017-12-12       Impact factor: 6.860

3.  Active surveillance before radiotherapy: Outcome and predictive factors for multiple biopsies before treatment.

Authors:  Alexandre Alcaidinho; Guila Delouya; Jean-Paul Bahary; Fred Saad; Daniel Taussky
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

4.  Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance.

Authors:  John W Davis; John F Ward; Curtis A Pettaway; Xuemei Wang; Deborah Kuban; Steven J Frank; Andrew K Lee; Louis L Pisters; Surena F Matin; Jay B Shah; Jose A Karam; Brian F Chapin; John N Papadopoulos; Mary Achim; Karen E Hoffman; Thomas J Pugh; Seungtaek Choi; Patricia Troncoso; Christopher J Logothetis; Jeri Kim
Journal:  BJU Int       Date:  2015-07-04       Impact factor: 5.588

Review 5.  Current Management Strategy for Active Surveillance in Prostate Cancer.

Authors:  Jamil S Syed; Juan Javier-Desloges; Stephanie Tatzel; Ansh Bhagat; Kevin A Nguyen; Kevin Hwang; Sarah Kim; Preston C Sprenkle
Journal:  Curr Oncol Rep       Date:  2017-02       Impact factor: 5.075

Review 6.  Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.

Authors:  Valentina Doldi; Marzia Pennati; Barbara Forte; Paolo Gandellini; Nadia Zaffaroni
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

Review 7.  Clinical and pathologic factors predicting reclassification in active surveillance cohorts.

Authors:  Pablo S Sierra; Shivashankar Damodaran; David Jarrard
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

8.  Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies.

Authors:  Pim J van Leeuwen; Amila Siriwardana; Monique Roobol; Francis Ting; Daan Nieboer; James Thompson; Warick Delprado; Anne-Marie Haynes; Phillip Brenner; Phillip Stricker
Journal:  Prostate Cancer       Date:  2016-04-11

9.  Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance.

Authors:  Andrew J Knighton; Tom Belnap; Kim Brunisholz; Kelly Huynh; Jay T Bishoff
Journal:  EGEMS (Wash DC)       Date:  2016-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.